All In MedTech

Company

Teleflex

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

Teleflex is on our public-company list (ticker TFX). Names searched as well: Arrow International. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

TFX

NYSE · TELEFLEX INC

Public float

$2.30B

Value of shares held by non-insiders on Jun 29, 2025

Revenue

$1.99B

Fiscal year ending Dec 31, 2025

Net income

-$906M

Fiscal year ending Dec 31, 2025

R&D spending

$145M

Fiscal year ending Dec 31, 2025

Cash

$430M

As of Sep 30, 2026

Long-term debt

$1.62B

As of Sep 30, 2026

Shares outstanding

39.7M

As of Nov 3, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025––$1.14B–
2024––$130M–
2023––$646M–
2022––$744M–
2021––$400M–

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Apr 9, 2021Equity

Issued in a merger or acquisition; not counted as money raised

$100K$200K1Rule 504Form D ↗Apr 22, 2021
Sep 23, 2009Equity$18.2M$18.2M13Rule 506Agent: Deutsche Bank Securities Inc.Form D ↗Sep 24, 2009

Company details

From the company's latest Form D.

Legal name
Arrow Allergy, Inc.; Sigma Pharmaceuticals Ltd
Headquarters
Erie, Colorado
Incorporated
Delaware in 2021
Entity type
Corporation
Revenue range
No Revenues
Industry filed under
Other Health Care

Executives, directors and promoters

As listed on the latest Form D.

    1 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Teleflex we have 5 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    The 8 newest of 61 since 2015.

    Search the Clearance Tracker

    58 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    4 more trials with a free account

    Reports received

    4,814

    Received Nov 1, 2025 to Nov 19, 2026. Includes 18 of another or unstated type.

    Malfunction reports

    4,532

    94% of reports

    Injury reports

    254

    5.3% of reports

    Death reports

    10

    0.2% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 233412311
    Jan 244562730
    Feb 243652310
    Mar 244023110
    Apr 243551921
    May 245673611
    Jun 244672600
    Jul 245152000
    Aug 244894410
    Sep 244232110
    Oct 244753822
    Nov 244355000
    Dec 243673740
    Jan 254512610
    Feb 253534110
    Mar 254191400
    Apr 253972610
    May 253842400
    Jun 254262200
    Jul 254332010
    Aug 253671910
    Sep 253771810
    Oct 253482900
    Nov 253723400
    Dec 253722110
    Jan 263651520
    Feb 263472130
    Mar 263832501
    Apr 264511800
    May 263571410
    Jun 264371514
    Jul 264312103
    Aug 263931807
    Sep 263092102
    Oct 263153121
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    7 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    1,195 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.